• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.40% Nasdaq Up 0.25%

    Alkermes plc (ALKS)

    -NasdaqGS
    55.48 Down 0.60(1.07%) 1:18PM EST - Nasdaq Real Time Price
    Prev Close:56.08
    Open:56.06
    Bid:55.39 x 200
    Ask:55.44 x 100
    1y Target Est:64.25
    Beta:2.00921
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:55.25 - 56.17
    52wk Range:27.14 - 60.74
    Volume:235,936
    Avg Vol (3m):1,231,780
    Market Cap:8.43B
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 1.07%8.43B
    LLYDown 0.12%80.52B
    GSKDown 0.21%97.00B
    ABTUp 0.06%69.58B

    Key Statistics

    Forward P/E (1 yr):162.94
    P/S (ttm):12.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.20
    Quarterly EPS Est (Dec-16) :0.04
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):9.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback